96942 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Platelet-derived growth factor [PDGF]
NOVEL PLATELET DERIVED GROWTH FACTOR PEPTIDE MIMETIC
#2Cell cultivation processes for preparing food products, products provided by said processes and a system for providing these processes
#3TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#4PDGF-D PRODOMAIN AND ITS MUTANT AND FUSION
#5STABLE HUMAN PLATELET LYSATE COMPOSITION, METHODS AND USES THEREOF
#6Isolation of Autologous Acellular Biological Therapeutics
#7NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO
#8MSC-NTF SPECIFIC EXOSOMES AND USE THEREOF
#9NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO
#10Saccharomyces Cerevisiae Lysate Containing One or More Cytokines, Preparation Method Therefor and Application Thereof in Cell-Cultured Meat
#11ENGINEERING OR INDUCING PDGF AND/OR PDGFR SIGNALING TO ENHANCE NK CELL THERAPY
#12BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#13ENGINEERING CELL LINES CAPABLE OF PROLIFERATION IN GROWTH FACTOR FREE MEDIA FORMULATIONS
#14SHEEP PDGFD, NUCLEIC ACIDS ENCODING PDGFD AND RECOMBINANT LENTIVIRUS, HOST CELL AND USE THEREOF
#15NOVEL PEPTIDE, COMPOSITIONS AND METHOD FOR DELIVERY OF AGENTS INTO CELLS AND TISSUES
#16METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#17CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING
#18Targeting anabolic drugs for accelerated fracture repair
#19METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#20METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#21METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#22METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#23METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#24METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#25REGENERATIVE CAR-T CELLS
#26COMBINATION GRAFTS FOR TISSUE REPAIR OR REGENERATION APPLICATIONS
#27AGENTS WHICH INHIBIT GADS DIMERIZATION AND METHODS OF USE THEREOF
#28METHOD FOR EXPRESSING AND PURIFYING PROTEIN BY USING CSQ-TAG
#29Peptide, compositions and method for delivery of agents into cells and tissues
#30PLATELET-DERIVED GROWTH FACTOR COMPOSITIONS AND METHODS OF USE THEREOF
#31PDGF RECEPTOR BETA BINDING POLYPEPTIDES
#32ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM
#33LYMPHANGIOGENESIS FOR THERAPEUTIC IMMUNOMODULATION
#34Compositions and methods relating to bone repair and regeneration
#35METHODS AND COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
#36PHARMACEUTICAL COMPOSITION CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TUMOR-PENETRATING PEPTIDE AND ANTIANGIOGENESIS AGENT ARE FUSED, FOR PREVENTING AND TREATING CANCER OR ANGIOGENESIS-RELATED DISEASES
#37TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR
#38ANABOLIC TARGETING STEM CELL GENE THERAPY FOR OSTEOPOROSIS
#39Heparin composition for treating ischemia
#40MSC-NTF specific exosomes and use thereof
#41LIQUID COMPOSITION COMPRISING VEGF ANTAGONIST
#42Molecular Size of Elastin-Like Polypeptide Delivery System for Therapeutics Modulates Deposition in the Placenta
#43Drug Evaluation Method
#44Methods for inducing synaptogenesis with synaptic growth factor activating compounds
#45NOVEL CONJUGATES AND USES THEREOF
#46PDGF receptor beta binding polypeptides
#47METHOD FOR EXTENDING HALF-LIFE OF PROTEIN
#48AGENTS WHICH INHIBIT GADS DIMERIZATION AND METHODS OF USE THEREOF
#49COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE
#50Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction
#51Compositions, methods, and systems for affinity-based protein identification and purification
#52Combination grafts for tissue repair or regeneration applications
#53METHOD FOR EXTENDING HALF-LIFE OF A PROTEIN
#54ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM
#55METHOD FOR THE PREPARATION AND PROLONGED STORAGE OF GROWTH FACTORS AND CYTOKINES OBTAINED FROM PLATELET RICH PLASMA
#56Methods and composition for detecting CAPN5
#57Non-integrating viral delivery system and methods related thereto
#58Delivery of therapeutic agents by a collagen binding protein
#59Method of synthesizing antagonist peptides for cell growth
#60Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen
#61Composition and Method for Therapeutic Agent Delivery During Pregnancy
#62USE OF VEGF-B FOR TREATING DISEASES INDUCED BY OXIDATIVE INJURY
#63USE OF VEGF-B FOR TREATING DISEASES INVOLVING NEOANGIOGENESIS
#64Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
#65Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid
#66Method for mass producing proteins in mesenchymal stem cells
#67Genetically engineered larvae for wound healing
#68Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseases
#69METHODS FOR DIAGNOSIS OF BLADDER CANCER
#70HYBRID CHIMERA POLYPEPTIDES AS DUAL INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND PLATELET-DERIVED GROWTH FACTOR RECEPTOR
#71CHIMERIC PROTEIN
#72Platelet-derived growth factor B mutant, preparation method therefor and use thereof
#73Delivery of therapeutic agents by a collagen binding protein
#74Expression cassette and vector comprising Alzheimer's disease-related mutant genes and cell line transformed by means of same
#75Binding-induced DNA nanomachines
#76Platelet-derived growth factor compositions and methods of use thereof
#77Platelet-derived growth factor compositions and methods of use thereof
#78PDGF receptor beta binding polypeptides
#79METHODS FOR ENHANCING THE DELIVERY OF ACTIVE AGENTS
#80Composition and method for therapeutic agent delivery during pregnancy
#81Polynucleotide encoding a fusion protein for improving skin conditions
#82Systemic and local ex vivo gene therapy of the skeleton
#83Methods of treating damaged cartilage tissue using growth factors fused to heparin binding sequences
#84PDGFRBETA-FC FUSION PROTEINS AND USES THEREOF
#85Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
#86CD34 STEM CELL-RELATED METHODS AND COMPOSITIONS
#87Cosmetic composition for improving skin conditions comprising fusion protein
#88Modified SAK gene for the production of recombinant proteins
#89Activated collagen scaffold materials and their special fused active restoration factors
#90Activated collagen scaffold materials and their special fused active restoration factors
#91Surface-active collagen membrane by peptide
#92Designed ankyrin repeat proteins binding to platelet-derived growth factor
#93Anticancer fusion protein comprising trail and a growth factor receptor inhibitor
#94PDGF receptor beta binding polypeptides
#95Modified SAK gene for the production of recombinant proteins
#96Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#97Signature Of Secreted Protein Isoforms Specific To Ovarian Cancer
#98PROTEOGLYCAN-BINDING PEPTIDES THAT MODULATE STEM CELL BEHAVIOR
#99CD34 Stem Cell-Related Methods and Compositions
#100Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof
#101PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS
#102Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#103METHOD OF TREATING HEPATOCELLULAR CARCINOMA
#104CLOTTABLE CONCENTRATE OF PLATELET GROWTH FACTORS AND PREPARATION METHOD THEREOF
#105Single branch heparin-binding growth factor analogs
#106Purification and Use of a Factor for Supporting Wound Healing
#107Methods and Compositions for PDGF-C Activation and Inhibition
#108ISOLATED MODIFIED HUMAN CHORIONIC GONADOTROPIN PROTEINS
#109Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#110Platelet derived growth factor (PDGF) nucleic acid ligand complexes
#111Activated collagen scaffold materials and their special fused active restoration factors
#112CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF
#113MATERIALS AND METHODS FOR PREPARING DIMERIC GROWTH FACTORS
#114Purification and use of a factor for supporting wound healing
#115Dimeric fusion proteins and materials and methods for producing them
#116Methods and compositions for PDGF-C activation and inhibition
#117CD34 stem cell-related methods and compositions
#118METHOD OF TREATING HEPATOCELLULAR CARCINOMA
#119Antibodies to PDGF-D
#120Single branch heparin-binding growth factor analogs
#121Platelet derived growth factor (PDGF) nucleic acid ligand complexes
#122In vivo amplification of neural progenitor cells
#123Methods of promoting cardiac repair using growth factors fused to heparin binding sequences
#124Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
#125Composition and method for modulating vasculogenesis for angiogenesis
#126Composition for coordinated VEGF and PDGF expression, and methods of use
#127Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
#128METHOD OF TREATING HEPATOCELLULAR CARCINOMA
#129Materials and methods for preparing dimeric growth factors
#130Platelet-derived growth factor D, DNA coding therefor, and uses thereof
#131Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#132Analysis and separation of platelet-derived growth factor proteins
#133High affinity oligonucleotide ligands to growth factors
#134Restoring vascular function
#135Chimeric protein
#136Sustained delivery of PDGF using self-assembling peptide nanofibers
#137Methods and compositions for PDGF-C activation and inhibition
#138Treatment of inflammatory bowel disease using growth factors
#139High affinity TGFbeta nucleic acid ligands and inhibitors
#140Antibodies to PDGF-D
#141Dimeric fusion proteins and materials and methods for producing them
#142Combination PDGF, KGF, IGF, and IGFBP for wound healing
#143RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
#144Method for stimulating connective tissue growth or wound healing
#145Novel polynucleotides and proteins encoded thereby
#146Method of treating hepatocellular carcinoma
#147Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#148Growth factor polypeptides and nucleic acids encoding same
#149Methods of preventing and treating inflammatory bowel disease
#150Method for expression of heterologous proteins in yeast
#151Platelet derived growth factor (PDGF) nucleic acid ligand complexes
#152Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof